microRNA-21 Expression as Prognostic and Therapeutic Response Marker in Chronic Myeloid Leukaemia Patients

BACKGROUND: Chronic myeloid leukaemia (CML) is a myeloproliferative disorder categorized by malignant transformation of a single stem cell of hematopoietic cells. microRNAs (miRNAs) belong to transcription regulators in hematopoiesis and their altered expression associates with pathogenesis of CML....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Asian Pac J Cancer Prev
Asıl Yazarlar: Beg Mirza, Masroor Ali, Guru, Sameer Ahmad, Abdullah, Saleh Mohammed, Rizvi, Aliya, Saxena, Alpana
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: West Asia Organization for Cancer Prevention 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6852824/
https://ncbi.nlm.nih.gov/pubmed/31450909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2019.20.8.2379
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller